Curi Bio
PrivateLast Round
Series B
Dec 2, 2025
Total Funding Raised
$24.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Curi Bio is a biotechnology company that provides a preclinical discovery platform combining human stem cells, systems, and data to accelerate the discovery of new medicines.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curi Bio Comparables
Compare Curi Bio with similar companies based on industry and business-model similarity.
Curi Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 2, 2025 | ||||
| Grant | Aug 23, 2023 | ||||
| Series A | Dec 29, 2021 |
Key People
Founding team and executive leadership
Curi Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A |
| UTC Investment | Series B, Series A |
| NIH RADx | Grant |
| DS Asset Management | Series B, Series A |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Launched a commercially available HCM isogenic pair.
- Mar 20, 2026
Partnered with Battelle to commercialize NMJ assay technology.
Curi Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curi Bio's valuation, stock price, and market status.
Is Curi Bio a public or private company?
Curi Bio is a private company.
What is the current stock price of Curi Bio?
Curi Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Curi Bio worth (valuation)?
Valuation information for Curi Bio is not publicly available.
Can I buy Curi Bio stock?
Curi Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curi Bio's last funding round?
Curi Bio's most recent funding round was Series B on December 2, 2025.
Who are the main investors in Curi Bio?
Key investors in Curi Bio include Dynamk Capital, NIH RADx.
Will Curi Bio IPO soon?
No public IPO plans have been announced for Curi Bio.
How can I track Curi Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curi Bio's secondary market activity and sign up for updates.